• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Roche Holding AG

+ Add to Watchlist

RHO6:GR

29.340 EUR 0.250 0.86%

As of 13:47:02 ET on 09/22/2014.

Snapshot for Roche Holding AG (RHO6)

Open: 29.090 Day's Range: 28.980 - 29.380 Volume: 530
Previous Close: 29.090 52wk Range: 23.480 - 30.000 1-Yr Rtn: +22.96%

Stock Chart for RHO6

No chart data available.
  • RHO6:GR 29.340
  • 1D
  • 1M
  • 1Y
29.090
Interactive RHO6 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RHO6

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 17.7921
Relative P/E vs. DAX -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2014) 1.9910
Est. PEG Ratio 2.6897
Market Cap (M EUR) 201,503.22
Shares Outstanding (M) 5,620.50
30 Day Average Volume 177
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.73%
Cash Dividend (USD) 0.9151
Dividend Ex-Date 03/06/2014
5 Year Dividend Growth 13.91%
Next Earnings Announcement 01/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RHO6

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for RHO6

Roche Holding AG develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, and respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.

Severin SchwanChief Executive OfficerAlan HippeChief Financial & IT Officer
Roland DiggelmannCOO:DiagnosticsGottlieb A KellerGeneral Counsel
More Company Profile & Key Executives for RHO6

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil